Health Reform and Cancer

From Discourse DB
Revision as of 14:34, March 11, 2010 by Yaron Koren (talk | contribs) (Text replace - 'America's Affordable Health Choices Act of 2009' to 'Patient Protection and Affordable Care Act')
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

This is an opinion item.

Author(s) Myrna Ulfik
Source The Wall Street Journal
Date July 30, 2009
URL http://online.wsj.com/article/SB10001424052970204886304574306693989102298.html
Quote
Quotes-start.png "Yes, developing more effective, less toxic treatments is expensive. The prices of new cancer therapies reflect the billion-dollar cost of developing each new drug. But such treatments can be life-saving, as they have been for me. Despite its warts, our system works. Carelessly tinkering with it will have a world-wide penalty—the stifling of new drug development." Quotes-end.png


Add or change this opinion item's references


This item argues against the position Act should be passed on the topic Patient Protection and Affordable Care Act.